Genmab Us
UEI: YRS2EBCGETM3
• CAGE: 9DV57
Overview
Parent Awardee
Company Description
Genmab is an international biotech company specializing in creation and development of differentiated antibody therapeutics for treatment of cancer
Name
Genmab Us
Website
Headquarters
Plainsboro, NJ
United States
United States
Federal recipient
GENMAB US INC
(UEI YRS2EBCGETM3, CAGE 9DV57)
is headquartered in Plainsboro NJ.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in March 2008 and
federally registered in
October 2022.
Federal Registration and Certifications
Legal Name
GENMAB US INC
Division Name
GENMAB US, INC.
UEI
YRS2EBCGETM3
CAGE Code
9DV57
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 14, 2008
Initial Registration
Oct. 4, 2022
Last Registration
March 20, 2025
Registration Activation
Aug. 23, 2024
Registration Expiration
Aug. 21, 2025
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
Country of Incorporation
DNK
Employees
>1500
Reported NAICS
Accepts Credit Cards
No